Headquartered in Bethesda, Maryland, near the nation's capital, Orano USA is a leading technology and services provider for decommissioning shutdown nuclear energy facilities, managing used nuclear fuel, conducting federal site clean-up and closure, and the sale of uranium, conversion, and enrichment services to the U.S. commercial and federal markets.
In the nuclear medicine field, Orano Med is developing a new generation of targeted therapies against cancer using the unique properties of lead-212 (212Pb), a rare alpha-emitting radioisotope and one of the more potent therapeutic payloads against cancer cells.
Decommissioning & Dismantling
Orano provides expertise throughout the entire decommissioning process for U.S. facilities: planning, program and project management, fuel handling, decontamination, dismantling, waste packaging and transport, and site restoration.
Discover
Federal Services
Orano Federal Services is a valued partner for environmental cleanup and advanced nuclear solutions with a relentless corporate focus on climate change.
Discover
Nuclear Medicine against cancer
Orano is at the forefront of research in nuclear medicine and is developing new radioisotopic therapies against cancer. In 2014, Orano Med established a Lead-212 production facility in Plano, Texas.
Discover
Uranium Sales & Services
Orano offers an array of customizable services spanning the entire uranium life cycle.
Discover
Used Fuel Management
Orano TN provides total system solutions for used nuclear fuel and radioactive waste management, including NUHOMS dry storage systems and shielded transport casks for offsite shipments.
Discover